Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein subunit gamma-10 (GNG10) is a component of the heterotrimeric G protein complex together with alpha and beta subunits. These complexes act downstream of G protein-coupled receptors (GPCRs) to transmit extracellular signals into intracellular responses. The gamma subunit, together with the beta subunit, forms a stable beta-gamma dimer that modulates various signaling effectors, including ion channels, adenylyl cyclases, and phospholipase C. GNG10 is ubiquitously expressed, and disruption of its expression or function can lead to distinct cellular and disease phenotypes, including cancer progression and neurodevelopmental disorders. While not a direct therapeutic target, it plays critical roles in multiple tissues by regulating the spatial and temporal specificity of GPCR signaling.
GNG10 is not a direct drug target; drugs modulating GPCR signaling may indirectly influence GNG10's function as part of G protein complexes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein subunit gamma-10 (GNG10).